IL15 and breast carcinoma: Another study showed that treatment of DC vaccine pulsed with truncated neu antigen, interleukin 15 (IL-15), and IL-15Rα reduced mammary carcinoma development and inhibited HER2-dependent Akt signaling pathway in HER2/neu transgenic mice.